Work

How should we proceed with disease-modifying treatments for multiple sclerosis?

Year: 1997

Type: article

Source: The Lancet

DOI: 10.1016/s0140-6736(05)61562-0

Authors: Peter-Brian Andersson, Emmanuelle Waubant, Donald E Goodkin

Institutions: University of California, San Francisco, University of California San Francisco Medical Center

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2023605654

FWCI: 2.395

Cites: 8

Cited by: 19

Related to: 10